Average Co-Inventor Count = 7.19
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ligand Pharmaceuticals, Inc. (5 from 134 patents)
2. Pharmacopeia Inc. (4 from 101 patents)
3. Venenum Biodesign, LLC (4 from 8 patents)
4. N.v. Organon (3 from 101 patents)
5. Bristol-myers Squibb Compnay (2 from 3,681 patents)
6. Pharmacopela Drug Discovery, Inc. (1 from 1 patent)
7. Pharmacopeia Drug Discovery, Inc. (52 patents)
17 patents:
1. 11773110 - Heterocycle amines and uses thereof
2. 11583538 - Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
3. 11306098 - Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors
4. 11236055 - Non-systemic TGR5 agonists
5. 11186593 - Heterocycle amines and uses thereof
6. 10669242 - toxin inhibitors
7. 10604533 - Heterocycle amines and uses thereof
8. 10030034 - Heterocycle amines and uses thereof
9. 9266874 - Heterocycle amines and uses thereof
10. 8350043 - Azinone and diazinone V3 inhibitors for depression and stress disorders
11. 7906504 - [object Object]
12. 7820649 - Quinazolinone and isoquinolinone acetamide derivatives
13. 7807686 - 2-(4-oxo-4H-quinazolin-3-yl)acetamides and their use as vasopressin V3 antagonists
14. 7479495 - N-heterocyclic inhibitors of TNF-α expression
15. 7365209 - Nitrogen heterocycle biaryls for osteoporosis and other diseases